Adicet Bio Inc. (ACET)
0.85
-0.05 (-5.43%)
At close: Mar 03, 2025, 3:59 PM
0.89
5.08%
After-hours: Mar 03, 2025, 04:11 PM EST
Adicet Bio Cash Flow Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 |
| Net Income | -142.66M | -69.79M | -62M | -36.68M | -28.14M | -9.3M | -33.78M | 33.48M | 29M | 22.33M | 22.33M | 16.98M | 8.97M | 6.58M | 8.63M | 13.47M |
| Depreciation & Amortization | 6.1M | 2.58M | 1.54M | 1.23M | 1.24M | 1.22M | 5K | 11.85M | 8.09M | 6.94M | 6.94M | 6.94M | 5.5M | 2.8M | 1.87M | 2.38M |
| Stock-Based Compensation | 20.26M | 17.13M | 12.51M | 5.26M | 1.18M | 2.48M | 470K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Working Capital | 1.94M | 849K | -9.18M | -12.71M | -186K | -7.76M | 2.87M | 63.76M | 51.39M | 26.65M | 19.48M | -302K | -10.4M | 9.71M | -15.92M | 7.33M |
| Other Non-Cash Items | 22.33M | 2.58M | 1.72M | -1.04M | -2.5M | -4.54M | 16.57M | -70.88M | -47.71M | -18.3M | -12.88M | -8.1M | 3.17M | -21.05M | -134.44M | -1.72M |
| Deferred Income Tax | n/a | n/a | 1.23M | 3.2M | n/a | n/a | 18K | 1.87M | 3.08M | 2.65M | 2.65M | 1.78M | -675K | -796K | 191K | -121.46M |
| Change in Working Capital | 252K | 2.74M | -6.06M | -13.52M | 341K | -8.05M | 4.26M | 27.48M | 29.44M | 10.06M | 2.9M | -5.5M | -3.79M | -4.08M | 144.71M | 121.46M |
| Operating Cash Flow | -93.72M | -44.77M | -51.05M | -41.55M | -27.88M | -18.18M | -11.55M | 8.34M | 25.06M | 25.48M | 23.73M | 13.27M | 14.04M | -15.5M | 22.51M | 15.42M |
| Capital Expenditures | -4.46M | -16.78M | -13.05M | -990K | -1.07M | -876K | -44K | -617K | -1.15M | -1.02M | -1.02M | -1.1M | -5.42M | -3.96M | -557K | -1.2M |
| Acquisitions | n/a | n/a | n/a | 64.11M | 118K | n/a | n/a | n/a | -86.14M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | -5.7M | -76.08M | -15.18M | -2.04M | -34K | -2.72M | -108K | -2.7M | -1.16M | -468K | n/a | -10.17M | n/a |
| Sales Maturities Of Investments | n/a | n/a | 10.25M | 57.79M | 29.1M | 7.5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | n/a | 10.25M | 64.11M | -46.86M | -7.5M | -6.71M | -8.32M | 4.08M | -1.67M | 2.66M | 477K | -63.31M | -2.15M | 6.67M | 2.6M |
| Investing Cash Flow | -4.46M | -16.78M | -2.8M | 115.22M | -47.93M | -16.06M | -44K | -8.97M | -85.92M | -2.8M | -1.06M | -1.78M | -69.2M | -6.11M | -4.06M | 1.4M |
| Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Common Stock Repurchased | -150K | n/a | n/a | n/a | n/a | n/a | -55.68M | n/a | -34.02M | -42.9M | -33.23M | -24.86M | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 236K | -1.85M | 4.56M | 303K | 76.94M | 11.05M | n/a | n/a | 70.53M | -14.31M | -14.31M | -15.29M | 49.97M | -2.44M | -4.26M | -6.03M |
| Financial Cash Flow | 236K | 41.51M | 242.69M | 303K | 76.94M | 11.05M | 64.95M | n/a | 70.53M | -14.31M | -14.31M | -15.29M | 49.97M | -2.44M | -4.26M | -6.03M |
| Net Cash Flow | -97.94M | -20.04M | 188.84M | 73.97M | 1.13M | -23.19M | 30.48M | -8.88M | 9.67M | 8.37M | 8.37M | -3.8M | -2.19M | -26.91M | 11.25M | 14.2M |
| Free Cash Flow | -98.18M | -61.55M | -64.1M | -42.54M | -28.95M | -19.06M | -11.6M | 7.73M | 23.91M | 24.45M | 22.71M | 12.17M | 8.61M | -19.46M | 21.95M | 14.22M |